ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Down-Regulation of Autophagy Correlates With Increased Apoptosis in the Kidney, But Not in the Liver, of Brain Dead Rats

    A. van Erp,1 R. Rebolledo,3 P. Ottens,1 J. Pirenne,2 H. Leuvenink,1 J.-P. Decuypere.2

    1Department of Surgery, University Medical Center Groningen, Groningen, Netherlands; 2Department of Microbiology and Immunology, Catholic University Leuven, Leuven, Belgium; 3Department of Surgery, University of Chile, Santiago, Chile.

    Organs from brain dead donors have inferior quality and show higher rejection rates after transplantation compared to living donors. Brain death (BD) in the donor…
  • 2015 American Transplant Congress

    ABO Incompatible Simultaneous Liver-Kidney Transplant With Positive Crossmatch. A Case Report

    T. Heffron,1 C. Kulig,2 P. Gauthier,2 B. Bista,2 S. Dionne,3 T. Pillen,1 M. Asolati.1

    1Surgery, Porter Adventist Hospital, Denver, CO; 2Medicine, Porter Adventist Hospital, Denver, CO; 3LABS, Inc., Centennial, CO.

    INTRODUCTION: Donor Specific (DS) antibodies and ABO incompatibility remain major immunological barriers in organ transplantation. Clinical evidence suggest the liver can protect a kidney from…
  • 2015 American Transplant Congress

    Native Kidney Biopsy Does Not Predict Post Liver Transplant Renal Outcomes

    D. Sawinski,1 A. Ganguli,1 M. Palmer, R. Bloom,1 P. Abt.

    1Renal Division, Univ. of Penn, Philadelphia, PA; 2Dept of Pathology, Univ. of Penn, Philadelphia, PA; 3Dept of Surgery, Univ. of Penn, Philadelphia, PA.

    Liver transplant (LT) recipients are at high risk of posttransplant renal disease but the extent of renal disease is often unrecognized in the pretransplant setting.…
  • 2015 American Transplant Congress

    Comparison of Renal Outcomes for Liver Transplant Recipients With Pretransplant Renal Dysfunction Receiving Sirolimus Or Tacrolimus With Rabbit Antithymocyte Globulin Induction

    B. Duhart,1 W. Ally,2 V. Rao,3 A. Krauss,4 J. Eason,3 J. Vanatta.3

    1University of Tennessee College of Pharmacy, Memphis, TN; 2Pharmacy, University of Virginia Medical Center, Charlottesville, VA; 3Surgery, Methodist University Hospital Transplant Institute/University of Tennessee Health Science Center, Memphis, TN; 4Pharmacy, Methodist University Hospital, Memphis, TN.

    Published data are limited describing renal outcomes in orthotopic liver transplant (OLT) recipients prescribed de novo sirolimus (SRL) maintenance immunosuppression and rabbit antithymocyte globulin (rATG).…
  • 2015 American Transplant Congress

    Renal Dysfunction After Liver Transplantation in Recipients With Pre-Transplant Normal Renal Function

    S. Lee,2 J. Lee,1 M. Kim,1 B. Kim,3 D. Joo,1 G. Choi,1 J. Choi,1 S. Kim.1

    1Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea; 2Surgery, Ajou University School of Medicine, Suwon, Republic of Korea; 3Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

    Background. Renal dysfunction is a severe complication associated with adverse outcomes after liver transplantation (LT). The aim of our study is to identify the incidence…
  • 2015 American Transplant Congress

    Renal Function Difference Between Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy and HBIG Combined With Entecavir in Liver Recipients

    J. Lee,1,2 J. Lee,1,2 J. Lee,3 M. Kim,1,2 M. Ju,1,2 G. Choi,1,2 J. Choi,1,2 S. Kim,1,2 D. Joo.1,2

    1Department of Transplantation Surgery, Severance Hospital, Yonsei University Health System, Seroul, Korea; 2Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea; 3Department of Surgery, CHA Bundang Medical Center, CHA University, Bundang, Korea.

    Background: To reduce the HBV reinfection after liver transplantation, anti-hepatitis B immunoglobulin (HBIG) alone or combination with antiviral nucleotide analogues are usually used regimen. However,…
  • 2015 American Transplant Congress

    Center-Level Variation of Simultaneous Liver-Kidney Utilization

    X. Luo, A. Massie, D. Segev.

    Johns Hopkins, Baltimore.

    Liver waitlist registrants with kidney disease may receive simultaneous liver-kidney (SLK) transplant, or liver-only (LT). Patient characteristics associated with SLK, and center-level variation in SLK…
  • 2015 American Transplant Congress

    Split and Living Donor Versus Whole Liver Transplantation for Hepatocellular Carcinoma in Adult Recipients: A Single Center Analysis

    O. Boillot, O. Guillaud, J. Dumortier.

    Liver Transplant Unit, Edouard Herriot Hospital, lyon, France.

    INTRODUCTIONThe use of partial liver grafts in the context of hepatocellular carcinoma (HCC) remains a matter ofdebate because of a supposed higher risk of cancer…
  • 2015 American Transplant Congress

    The Product of Donor Age and Preoperative MELD, D-MELD, Predicts Surgical Outcomes After LDLT, When Using Small Graft

    A. Tanemura, S. Mizuno, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, M. Usui, H. Sakurai, S. Isaji.

    Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

    Background:Donor-recipient match is recognized as the factor well predicting recipient outcome in deceased donor liver transplantation. The aim of the present study is to evaluate…
  • 2015 American Transplant Congress

    Live Donor Vs Deceased Donor Liver Transplantation Results in Identical Outcome in Recipients With Acute Liver Failure – An Important Choice for Critical Ill Patients

    N. Goldaracena, G. Sapisochin, J. Echeverri, M. Kaths, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.

    Multi Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada.

    Introduction: Live donor liver transplantation (LDLT) is a valid alternative to deceased donor liver transplantation (DDLT) in patients suffering from acute liver failure (ALF). Rapid…
  • « Previous Page
  • 1
  • …
  • 1429
  • 1430
  • 1431
  • 1432
  • 1433
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences